10/15/2026
Ohio State researchers are continuing their pioneering work in CAR T-cell therapy with a clinical trial that shows improved outcomes for patients with B-cell blood cancers.
Results from a phase I clinical trial led by the OSUCCC – James show a possible way to improve therapy options for patients with relapsed or